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Abstract
In adenovirus type 12 transformed cells, the down-regulation of MHC class I transcription contributes to the tumorigenic phenotype and
is solely mediated by Ad12 E1A. Previous in vitro studies with class I enhancer sequences have indicated that there is an increased binding
of repressor COUP-TFII and its associated HDAC and a decreased binding of activator NF-B. In this study, we used chromatin
immunoprecipitation (ChIP) assay in order to determine in vivo whether these proteins regulate class I transcription by affecting chromatin.
The ChIP assay revealed that there is lack of chromatin histone acetylation in the region of the class I enhancer in Ad12-transformed cells.
This is regulated by histone deacetylation as it was further demonstrated in vivo that COUP-TFII and HDAC are associated with the class
I enhancer chromatin. In agreement with in vitro studies, NF-B could be recruited to the class I enhancer following induction by TNF-.
However, this enhancer-bound NF-B failed to up-regulate class I expression because the class I enhancer chromatin remained repressed
as a result of histone deacetylation by HDAC in association with COUP-TFII. Thus, we have demonstrated for the first time that repression
of chromatin through histone deacetylation is a major mechanism in down-regulating class I transcription in Ad12-transformed cells. Finally,
Ad12 E1A, a non-DNA binding protein, was shown to be present in the natural protein complex bound to the class I enhancer.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Cell surface major histocompatibility complex (MHC)
class I antigens are important for cell-mediated immune
surveillance carried out by cytotoxic T lymphocytes
(CTLs). In cells transformed by adenovirus type 12 (Ad12),
cell surface MHC class I antigens are diminished, which
increases the tumorigenic potential of these transformed
cells through avoidance of CTL detection (Schrier et al.,
1983; Eager et al., 1985; reviewed by Williams et al., 2002).
This reduction of class I antigen surface expression is due to
the down-regulation of class I gene transcription and is
solely mediated by effects of Ad12 E1A on the class I
enhancer (Bernards et al., 1983; Vasavada et al., 1986;
Ackrill and Blair, 1988; Friedman and Ricciard, 1988; Ge et
al., 1994). The class I enhancer contains a binding site (R1
site) for the transcription activator NF-B and a second
binding site (R2 site) for nuclear hormone receptors
(Kimura et al., 1986; reviewed by Williams et al., 2002). In
vitro studies have shown in Ad12-transformed cells that
chicken ovalbumin upstream promoter-transcription factor
II (COUP-TFII) binds to the R2 site and acts as a repressor
of class I transcription (Ge et al., 1992; Krali et al., 1992;
Liu et al., 1994; Smirnov et al., 2001; see Fig. 1). One
possible mechanism by which COUP-TFII exerts this re-
pressive effect is through its association with histone
deacetylases (HDACs), which function to repress transcrip-
tion by modifying chromatin (Smirnov et al., 2000). In
addition, there is a loss of DNA binding activity of the
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transcription activator NF-B to the R1 site of the class I
enhancer (Kushner et al., 1996; Liu et al., 1996; Hou et al.,
2002; see Fig. 1). Recent studies suggest that this increased
binding of a repressor and decreased binding of an activator
to the class I enhancer constitutes a “fail-safe” mechanism
used by Ad12 E1A to ensure that class I transcription
remains shut down under different physiological conditions
(Hou et al., 2002).
While our previous in vitro studies convincingly indi-
cated that presence of COUP-TFII and absence of NF-B
are responsible for down-regulation of class I transcription,
it remains essential to demonstrate in vivo if these factors
are physiologically associated with the class I enhancer and
to determine the mechanism by which they mediate tran-
scriptional repression. In this study we approached this issue
by employing chromatin-immunoprecipitation (ChIP) as-
say. Unlike conventional methods in measuring protein/
DNA interactions, e.g. electrophoretic mobility shift assay
(EMSA) and transient transfection, the ChIP assay has the
major advantage of permitting in vivo the examination of
the interaction of promoter regions with protein complexes
in the natural genomic state. In addition, ChIP assay pro-
vides a direct means to study the histone acetylation status
of specific chromatin regions.
Here we demonstrate for the first time that the repressor
COUP-TFII, but not activator NF-B, is physiologically
associated with the class I enhancer, and that chromatin
repression mediated by HDAC is a major mechanism for
class I transcriptional down-regulation. Finally, Ad12 E1A,
the viral mediator of class I transcription shut-off, is a
component of the protein complex bound to the class I
enhancer.
Results
There is lack of histone acetylation of the MHC class I
enhancer in Ad12-transformed cells
Transcription of MHC class I genes is shut down in
tumorigenic Ad12-transformed cells (Ackrill and Blair,
1988; Friedman and Ricciard, 1988) and correlates with loss
of binding of the activator NF-B and gain of binding of the
repressor COUP-TFII to the class I enhancer (Liu et al.,
1994; Liu et al., 1996; Smirnov et al., 2001; Hou et al.,
2002). The direct converse of these activities is observed in
non-tumorigenic Ad5-transformed cells. In this study, we
wished to determine if chromatin repression is associated
with loss of MHC class I transcription in Ad12 transformed
cells, especially since our in vitro studies showed that an
HDAC activity co-immunoprecipitated with COUP-TFII
(Smirnov et al., 2000). To address this question we mea-
sured the level of histone acetylation by employing anti-
acetyl histone antibodies in ChIP assay, since histone acet-
ylation of chromatin is a hallmark of active transcription
(Berger, 2001). The MHC class I enhancers from the Ad12-
Fig. 1. Transcription of MHC class I is regulated by differential binding of repressor COUP-TFII and activator NF-B to the class I enhancer in adenovirus
transformed cells. MHC class I transcription is down-regulated in tumorigenic Ad12 compared to non-tumorigenic Ad5-transformed cells. In Ad12-
transformed cells, there is increased binding of COUP-TFII to the R2 site and decreased binding of NF-B to the R1 site of the class I enhancer. Horizontal
arrow, transcriptional start site.
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and Ad5-transformed cells lines, 12A1 and KAd5 respec-
tively, were examined. The 12A1 and KAd5 cell lines have
been highly characterized and are representative of all Ad12
and Ad5 cells studied (Eager et al., 1985; Liu et al., 1994;
Kushner et al., 1996; Liu et al., 1996; Smirnov et al., 2001).
Briefly, the ChIP assay was performed by incubating anti-
body with the supernatant of sonicated chromatin from cells
treated with formaldehyde cross-linking reagent that pre-
serves natural DNA/protein complexes (see Materials and
methods). The immunoprecipitated chromatin fragments
were amplified by PCR using specific oligonucleotide prim-
ers flanking the class I enhancer and visualized on an aga-
rose gel. The PCR signal is thus an indication of the pres-
ence of a regulatory protein in a complex binding to the
class I enhancer DNA. As shown in Fig. 2, histone acety-
lation of the class I enhancer was detected only in the
Ad5-transformed cell line (compare lanes 1 and 2). These in
vivo results indicate that in Ad12-transformed cells, the
chromatin in the region of the class I enhancer assumes a
much less active state than that in Ad5-transformed cells.
This is in accord with our in vitro studies which have shown
that class I transcription is down-regulated in Ad12-trans-
formed cells.
COUP-TFII and HDACs are present in a complex
binding to the MHC class I enhancer in Ad12-
transformed cells
It was previously shown in vitro that the binding of
COUP-TFII to the R2 site of the MHC class I enhancer is
significant in Ad12 and negligible in Ad5-transformed cells
(Liu et al., 1994; Smirnov et al., 2001), and that histone
deacetylase activity is associated with COUP-TFII (Smir-
nov et al., 2000). Since the above results and our previous
in vitro studies suggest that histones associated with the
class I enhancer region are deacetylated in Ad12-trans-
formed cells, it was important to prove in vivo that COUP-
TFII and HDACs are actually present on the class I en-
hancer. A ChIP assay was performed using sonicated
chromatin samples from KAd5 and 12A1 cells, and anti-
bodies against COUP-TFII and HDAC4. As shown in Fig.
3A, both COUP-TFII and HDAC4 were found to be present
on the class I enhancer in 12A1 cells (lanes 3 and 4), but not
in KAd5 cells (lanes 1 and 2). An antibody against HDAC4
was used in Fig. 3A since it resulted in the strongest PCR
signal among several HDAC family members tested, in-
cluding HDAC4, HDAC5, HDAC6, and HDAC7 (Fig. 3B).
It should be noted that although HDAC4 and HDAC5 are
clearly present in the class I chromatin complex, the poten-
tial differences in antibody affinities make it difficult to
determine if a particular HDAC species is dominant in the
complex.
NF-B is recruited to the MHC class I enhancer in Ad12-
transformed cells following treatment with TNF-
Critical to transcriptional activation of the class I pro-
moter is binding of NF-B (p50/p65) to the R1 site of the
Fig. 3. COUP-TFII and HDACs complex to the MHC Class I enhancer
chromatin in Ad12-transformed cells. (A) Sonicated chromatin from Ad5-
transformed (KAd5) and Ad12-transformed (12A1) cells was immunopre-
cipitated with 5 l of anti-COUP-TFII (lanes 1 and 3) or anti-HDAC4
(lanes 2 and 4) antibodies or was used as a negative control with no
antibody (lanes 5 and 6). Samples were then amplified by PCR using
primers flanking the class I enhancer region, and PCR products were
resolved on an agarose gel. To compare the relative amounts of chromatin
used in the immunoprecipitation, 1% of input from each cell type was
amplified by PCR, as shown at the bottom of the figure. (B) Sonicated
chromatin from 12A1 cells was divided into 5 aliquots, each of which was
then immunoprecipitated with anti-HDAC4 (5 l), anti-HDAC5 (20 l),
anti-HDAC6 (20 l), anti-HDAC7 (20 l), or no antibody. Samples were
then amplified by PCR using primers flanking the class I enhancer region,
and PCR products were resolved on an agarose gel. These results are
representative of multiple independent experiments.
Fig. 2. The histones of MHC class I enhancer chromatin are not acetylated
in Ad12-transformed cells. Sonicated chromatin from Ad5-transformed
(KAd5) and Ad12-transformed (12A1) cells was immunoprecipitated with
5 l of anti-acetyl-histone antibodies (lanes 1 and 2) or was used as a
negative control with no antibody (lanes 3 and 4). Samples were then
amplified by PCR using primers flanking the class I enhancer region, and
PCR products were resolved on an agarose gel. To compare the relative
amounts of chromatin used in the immunoprecipitation, 1% of input from
each cell type was amplified by PCR, as shown at the bottom of the figure.
This result is representative of multiple independent experiments.
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class I enhancer. DNA band-shift experiments have shown
that binding of NF-B to the class I enhancer is strong in
Ad5-transformed but is negligible in Ad12-transformed
cells (Kushner et al., 1996; Liu et al., 1996; Hou et al.,
2002). Consistent with these in vitro findings, the ChIP
assay confirms that there is a significantly greater presence
of NF-B on the class I enhancer in Ad5-transformed cells
than in Ad12-transformed cells (compare lanes 1 of Figs.
4A and 4B ). Also in agreement with previous findings that
cytokines such as TNF- can induce the binding of NF-B
to the R1 oligonucleotide in Ad12-transformed cells, the
ChIP assay demonstrates that NF-B is recruited to the class
I enhancer in Ad12-transformed cells following treatment
with TNF- (Fig. 4B, lane 2).
Class I enhancer chromatin repression by HDAC
dominates activation by NF-B in Ad12-transformed cells
It is well known that TNF- can stimulate NF-B DNA
binding and transcriptional activation, in part, by mediating
histone acetylation through coactivators containing histone
acetyltransferase activity (Gerrritsen et al., 1997; Zhong et
al., 1998; Sheppard et al., 1999). As demonstrated above
(Fig. 4B), in Ad12-transformed cells NF-B binding to the
class I enhancer can be induced by TNF-. Interestingly,
our earlier findings indicated that activated NF-B fails to
up-regulate class I transcription in the presence of COUP-
TFII and its associated HDAC (Smirnov et al., 2001; Hou et
al., 2002). However, the mechanism by which COUP-TFII/
HDAC prevents class I transcriptional activation by NF-B
is not clear. To address this question, we investigated the
status of chromatin histone acetylation of the class I en-
hancer following activation of NF-B by TNF- and relief
of COUP-TFII repression by the HDAC inhibitor TSA. As
shown in Fig. 5 (lane 1), there was negligible histone acet-
ylation of the class I enhancer region in Ad12-transformed
cells, as expected (Fig. 2, lane 2). Interestingly, TNF-
treatment alone failed to increase histone acetylation of the
class I enhancer region (Fig. 5, lane 3). By contrast, the
level of histone acetylation was significantly increased upon
TSA treatment (lane 2). As compared to TSA treatment
alone (lane 2), the combined treatment of TNF- and TSA
(lane 4) resulted in a discernible increase in the level of
histone acetylation (40%, as determined by normalizing
the signal from the various treatments against their respec-
tive 1% inputs). This histone acetylation can be reversed by
removal of TSA, despite the constant presence of TNF-
(data not shown). These results indicate that COUP-TFII
acts to repress class I transcription by mediating histone
deacetylation through its interaction with HDAC. More-
over, this COUP-TFII mediated chromatin repression can-
not be overcome solely by the recruitment of NF-B to the
class I enhancer in Ad12-transformed cells. These findings
provide an explanation for our previous Northern analyses
showing that class I mRNA levels cannot be elevated by
TNF- treatment alone unless COUP-TFII repression is
relieved (Hou et al., 2002).
Reduced class I surface expression by COUP-TFII and
HDAC transcriptional repression can not be overcome by
induced NF-B in Ad12-transformed cells
It is well established that in Ad12-transformed cells, the
reduction of class I mRNA levels correlates with the lack of
Fig. 5. Histone deacetylation is not reversed by TNF- induced NF-B
binding to the class I enhancer chromatin in Ad12-transformed cells.
Sonicated chromatin from Ad12-transformed (12A1) cells untreated (lane
1), TSA treated (100 nM for 2 h, lane 2), TNF- treated (10 ng/ml for 2 h,
lane 3), or TSA plus TNF- treated (lane 4) was immunoprecipitated with
5 l of anti-acetyl-histone antibody or was used as a negative control with
no antibody (lane 5). Samples were then amplified by PCR using primers
flanking the class I enhancer region, and PCR products were resolved on an
agarose gel. To compare the relative amounts of chromatin, 1% of input of
the untreated and treated cells was amplified by PCR, as shown at the
bottom of the figure. This result is representative of multiple independent
experiments.
Fig. 4. TNF- stimulates NF-B binding to the MHC Class I enhancer
chromatin in Ad12-transformed cells. (A) Sonicated chromatin from Ad5-
transformed (KAd5) cells was immunoprecipitated with 5 l of anti-p65
(lane 1) antibody or was used as a negative control with no antibody (lane
2). Samples were then amplified by PCR using primers flanking the class
I enhancer region, and PCR products were resolved on an agarose gel. One
percent of input was amplified by PCR, as shown at the bottom of the
figure. (B) Sonicated chromatin from Ad12-transformed (12A1) cells un-
treated (lane 1) or TNF- treated (10 ng/ml for 2 h, lane 2) was immuno-
precipitated with 5 l of anti-p65 antibody or was used as a negative
control with no antibody (lane 3). Samples were then amplified by PCR
using primers flanking the class I enhancer region, and PCR products were
resolved on an agarose gel. To compare the relative amounts of chromatin,
1% of input of the untreated and treated cells was amplified by PCR, as
shown at the bottom of the figure. These results are representative of
multiple independent experiments.
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cell surface class I antigens (Schrier et al., 1983; Eager et
al., 1985; Friedman and Ricciardi, 1988). Here, we inves-
tigated by FACS analysis whether the ability to increase
chromatin acetylation on the class I enhancer (Fig. 5) will
lead to the elevation of class I surface antigen levels. As
shown in Fig. 6, treatment of 12-1 cells with TNF-, which
recruits activator NF-B to the class I enhancer, failed to
increase the levels of cell surface MHC class I antigens
(compare panel 2 with 1). By contrast, treatment with TSA,
which relieves the chromatin repression by HDAC, resulted
in a substantial increase of cell surface class I antigens (Fig.
6, compare panel 3, with 26.33% positively stained cells,
and panel 1, with 0.86% positive cells). Finally, the com-
bined treatment of TNF- and TSA caused an even further
increase of cell surface class I antigens (Fig. 6, compare
panel 4, with 49.79% positive cells, and panel 3, with
26.33% positive cells). These FACS results directly parallel
those of the histone acetylation ChIP assay (Fig. 5) in that
both chromatin repression and reduction of class I surface
expression mediated by COUP-TFII and HDAC cannot be
overcome by induced NF-B in Ad12-transformed cells.
There is thus a link between regulation of class I transcrip-
tion at the level of chromatin and the expression of class I
antigens on the cell surface.
Ad12 E1A is present in class I enhancer complexes on
both the repressed and activated chromatin
It has been demonstrated that the MHC class I shutdown
in Ad12-transformed cells is mediated by E1A protein (Ber-
nards et al., 1983; Vasavada et al., 1986). However, it has
never been shown whether Ad12 E1A, a protein which does
not directly bind to DNA, is physically present in the com-
plex bound to the MHC class I enhancer. As shown in Fig.
7 (lane 1), a ChIP assay using Ad12 E1A-specific antibodies
clearly indicated that Ad12 E1A is indeed a component of
Fig. 6. In Ad12-transformed cells, class I surface expression is not up-regulated by TNF- induced NF-B unless HDAC repression is relieved.
Ad12-transformed 12-1 cells untreated (panel 1), TNF- treated (10 ng/ml for 48 h, panel 2), TSA treated (100 nM for 48 h, panel 3), or TSA plus TNF-
treated (panel 4) were analyzed by FACS analysis using anti-rat MHC class I monoclonal antibody RT1.A (OX-27). Indicated are the percentage of cells
positively stained and the mean fluorescent intensity of all cells.
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the protein complex bound to the class I enhancer. Follow-
ing treatment with TNF- and TSA, Ad12 E1A protein
remained present in the complex that is bound to the class I
enhancer (lane 2). Thus, Ad12 E1A is a part of class I
enhancer complexes associated with both repressed and
activated chromatin.
Discussion
One means by which adenovirus type 12 transformed
cells attain tumorigenicity in immunocompetent host is to
avoid CTL detection by diminishing MHC class I antigen
expression (Schrier et al., 1983; Eager et al., 1985). The
only viral gene required to mediate this event is Ad12 E1A,
which is responsible for the down-regulation of class I
transcription by targeting the class I enhancer (Bernards et
al., 1983; Vasavada et al., 1986). In vitro studies indicated
that repressor COUP-TFII is recruited to the class I en-
hancer and binding of activator NF-B is prevented (Liu et
al., 1994; Liu et al., 1996; Kushner et al., 1996; Smirnov et
al., 2001; Hou et al., 2002). Interestingly, while NF-B is
induced to bind DNA by cytokine treatment of Ad12 trans-
formed cells, it fails to overcome the class I transcriptional
repression (Smirnov et al., 2001; Hou et al., 2002).
These earlier in vitro results, employing EMSA, proved
that COUP-TFII and NF-B have the potential to directly
bind to specific class I enhancer oligonucleotides. However,
EMSA is limited in that it does not measure protein asso-
ciations in the natural context of chromatin. By contrast,
ChIP assay is able to measure proteins associated with
specific chromatin sequences under varying physiological
conditions. Another advantage is that the cross-linking fea-
ture of the ChIP assay allows detection of proteins that bind
directly to DNA, as well as non-DNA binding cofactors,
such as HDAC, that are components of DNA-bound protein
complexes. In addition, ChIP assay can also be used to
detect histone acetylation of specific chromatin regions,
which is a hallmark of chromatin activation.
By utilizing ChIP assay in this study, we provide in vivo
evidence that COUP-TFII, but not NF-B, is associated
with the class I enhancer in Ad12-transformed cells. Impor-
tantly, we show that COUP-TFII mediates down-regulation
of class I transcription by recruiting HDAC to the class I
enhancer. Moreover, we demonstrate definitively for the
first time that repression of chromatin through histone
deacetylation is a major mechanism in down-regulating
class I transcription. This chromatin repression (ChIP assay,
Fig. 5) and the resulting reduction of class I antigen expres-
sion (FACS analysis, Fig. 6) cannot be overcome solely by
cytokine-induced activator NF-B, which is completely
consistent with previous in vitro results. Finally, Ad12 E1A,
a non-DNA binding protein, is shown by ChIP assay to be
present in the natural protein complex bound to the class I
enhancer.
The mechanism by which class I transcription is down-
regulated in Ad12-transformed cells appears to be unique.
As seen in the model presented in Fig. 8 (panel A), activator
NF-B is present in the nucleus but fails to bind to the class
I enhancer R1 site. COUP-TFII, bound to the R2 site of
class I enhancer, is a novel negative regulator of class I
transcription seen so far only in the Ad12-transformed cell
system. In this study we demonstrated that COUP-TFII
mediates repression of chromatin and class I transcription
through its association with HDAC. Others have also sug-
gested that COUP-TFII may negatively regulate transcrip-
tion by contacting TFIIB, a component of the transcription
initiation complex (Tsai and Tsai, 1997). These two mech-
anisms of COUP-TFII repression are not mutually exclusive
in that they may both play a role in class I down-regulation.
Surprisingly, NF-B is induced by cytokines (TNF- and
IL-1) to bind to the class I enhancer, but is incapable of
activating class I transcription (Fig. 8, panel B). This is due
to the strong negative effects exerted by COUP-TFII
through histone deacetylation and chromatin repression.
Verification of this dominant role of COUP-TFII can be
seen when COUP-TFII-associated HDAC activity is inhib-
ited by TSA, which permits histone acetylation, enabling
NF-B to further activate class I transcription and surface
expression by stimulating histone acetylation and the tran-
scription initiation complex (Fig. 8, panel C). This study
thus provides an insight into the dynamics of class I tran-
scriptional regulation in tumorigenic Ad12-transformed
cells.
Finally, we have shown that Ad12 E1A, a non-DNA
binding protein, is present on class I chromatin, presumably
through protein-protein interaction. This is relevant since
Ad12 E1A solely mediates the down-regulation of class I
transcription. E1A is known to be a component of the
mediator complex (Boyer et al., 1999), and binds to p300
(Wang et al., 1993), NF-B p50 subunit (Hou and Ricciardi,
unpublished), and transcription initiation proteins such as
TAFs (Geisberg et al., 1995; Mazzarelli et al., 1997). How-
ever, it remains to be determined how these E1A interac-
Fig. 7. Ad12 E1A is present in complexes bound to repressed and activated
class I enhancer chromatin. Sonicated chromatin from Ad12-transformed
(12A1) cells untreated (lane 1) or treated (100 nM TSA plus 10 ng/ml
TNF- for 1 h, lane 2) was immunoprecipitated with 5 l of anti-Ad12
E1A antibody or was used as a negative control with no antibody (lane 3).
Samples were then amplified by PCR using primers flanking the class I
enhancer region, and PCR products were resolved on an agarose gel. To
compare the relative amounts of chromatin, 1% of input of untreated and
treated cells was amplified by PCR, as shown at the bottom of the figure.
This result is representative of multiple independent experiments.
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Fig. 8. Model for the mechanism by which chromatin repression by COUP-TFII and HDAC dominates activator NF-B in regulating class I transcription
in Ad12-transformed cells. A. In untreated cells, activator NF-B (p50/p65) fails to bind to class I enhancer DNA, while HDAC is recruited to the enhancer
by repressor COUP-TFII to mediate histone deacetylation and chromatin repression, resulting in class I transcription shut-off. B. In TNF- treated cells, even
though activator NF-B is induced to bind to the class I enhancer, it fails to activate class I transcription due to chromatin repression mediated by COUP-TFII
and HDAC. C. In TSA and TNF- co-treated cells, the activity of HDAC is inhibited by TSA, which permits histone acetylation, enabling NF-B to further
activate class I transcription by stimulating histone acetylation and the transcription initiation complex (TIC).
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tions influence class I transcription in Ad12-transformed
cells.
Materials and methods
Cells, antibodies and reagents
Mouse Ad12-transformed cell line 12A1 and Ad5-trans-
formed cell line KAd5, and rat Ad12-transformed cell line
12-1 were previously described (Eager et al., 1985; Jelinek
et al., 1994). Anti-p65 antibody was from Nancy Rice (Na-
tional Cancer Institutes). Antibodies against COUP-TFII
and 13S Ad12 E1A were previously described (Liu et al.,
1994; Scott et al., 1984). Anti-HDAC4 and anti-acetyl-
histone antibodies were purchased from Upstate Biotech
(Waltham, MA), and antibodies against HDAC5, 6, and 7
were purchased from Santa Cruz Biotech (Santa Cruz, CA).
For treatment of cells, recombinant murine TNF- was from
R&D Systems Inc. and TSA was from Biomol (Plymouth
Meeting, PA).
ChIP assay
ChIP assay was a modification of the protocol from
Upstate Biotech. Cells from one 10 cm dish (approxi-
mately 1.5  107 cells) were cross-linked by adding
formaldehyde directly into the culture media to a final
concentration of 1% and incubated at room temperature
for 10 min. Media were then poured out, cells were then
rinsed three times with PBS, scraped in PBS, and pel-
leted. Cell pellets were resuspended in 0.1 ml of the lysis
buffer (included in the ChIP assay kit from Upstate
Biotech), followed by adding 0.4 ml of the dilution buffer
(included in the ChIP assay kit from Upstate Biotech).
Cell lysates (1 ml) were sonicated 12 times for 30 sec
each, at an energy level of 30% using a Sonifier Cell
Disruptor (manufactured by Branson Sonic Power Inc.,
Danburg, CT). For ChIP assays performed with anti-
acetyl-histone antibody, cell lysates were sonicated only
twice for 5 sec each. Sonicated chromatin samples were
centrifuged for 2 min in a microcentrifuge. Supernatants
(0.5 ml) were immunoprecipitated with antibodies
(amount indicated in figure legends) and rotated at 4°C
for a minimum of 3 h. Sixty microliters of protein-A
agarose beads (50% slurry) were added to the superna-
tants and rotated for 30 min. The beads were then rinsed
briefly in the low salt buffer (included in the ChIP assay
kit from Upstate Biotech), washed for 5 min each in the
high salt buffer and the LiCl buffer (included in the ChIP
assay kit from Upstate Biotech), and finally rinsed briefly
in TE. Immunoprecipitates were then resuspended in 0.5
ml of TE and 50 l of 2 M NaCl and DNA was eluted by
reverse cross-linking at 65°C for a minimum of 1 h with
occasional agitation. Eluated DNA was extracted with
0.5 ml of phenol/chloroform and ethanol-precipitated.
DNA pellets were resuspended in 50 l of water and
were amplified by PCR. To compare the input of soni-
cated chromatin used in the ChIP assays, 1% of sonicated
chromatin before immunoprecipitation was examined.
PCR amplification
The forward PCR primer (5-GGGTTCAGGCAAAG-
TCTTAG-3) represents 211 to 231 of the mouse H2Kd
promoter region. The reverse PCR primer (5-GACCT-
GACCCAGGTTAGGTG-3) represents 118 to 138 of
the mouse H2Kd promoter region. After 30 cycles, PCR
reaction products (25 l) were resolved on a 1% agarose
gel.
FACS analyses
FACS analyses were performed on a Becton Dickinson
FACStarplus as previously described (Eager et al., 1985).
Anti-rat MHC class I monoclonal antibody RT1.A (OX-27)
was purchased from Cedarlane Laboratories (Ontario,
Canada).
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